New approaches for enhancing the photosensitivity, antibacterial activity, and controlled release behavior of non-porous silica-titania nanoplatforms.

This research presents a new approach for the synthesis of inorganic nano-platforms containing >2 layers. Nano-platforms were characterized using scanning electron microscopy, X-ray diffraction, fluorescence and Fourier transform infrared spectroscopy, fluorescence microscopy, dynamic light scattering, thermogravimetric analysis, Brunauer-Emmett-Teller, etc. Since it has been reported that the maximum tolerable dose of non-porous silica nanoparticles (NPs) in in-vivo studies is higher than that of mesoporous silica, the non-porous silica was prepared. Curcumin (CUR) was trapped between the surfaces of the spherical non-porous silica and titania NPs (<100 nm) as both fluorescent and therapeutic agents, thus resulting in increased loading capacity of the non-porous silica NPs, as well as providing significant photosensitivity, antibacterial activity, and controlled release. In addition, the surface of NPs was enriched with Methyl violet-10B (MV-10B), and Rhodamine B (RhB). Silica@CUR@titania exhibited approximately 9-fold higher fluorescence intensity than silica@CUR NPs. This finding enabled us to design nano-platforms with minimum toxic effect due to low contents of RhB for bioimaging applications. The antimicrobial efficiency of nano-platforms was evaluated against P. aeruginosa, E. coli, S. typhimurium, K. pneumonia, S. epidermidis, S. aureus, B. subtilis, B. cereus, and E. faecalis. It was concluded that titania markedly lowered the minimum inhibitory concentration values (MICs) of CUR against all bacteria except B. subtilis and P. aeruginosa. Theoretical simulation was also performed to clarify the accumulation of functionalized NPs in tumor tissue.

Radioactive cesium ion removal from wastewater using polymer metal oxide composites.

Radioactive cesium ion (Cs-137) removal from wastewater was investigated by novel composite adsorbents, chitosan-bone powder (CS-KT) and chitosan-bone powder-iron oxide (CS-KT-M) at 25 and 50 °C. The characterization of adsorbents was performed by Fourier-Transform Infrared Spectroscopy (FT-IR), Scanning Electron Microscope (SEM), X-Ray Diffraction (XRD), Brunauer-Emmett-Teller and Barrett-Joyner-Hallenda (BET-BJH), and Atomic Force Microscopy (AFM) analyses. While BET surface areas of CS-KT and CS-KT-M adsorbents were found to be 131.5 and 144.9 m2/g, respectively, average pore size and pore volume values were 4.69 nm/0.154 cm3/g and 7.49 nm/0.271 cm3/g, respectively. Amongst Freundlich, Langmuir, and Dubinin-Radushkevich (D-R) models, Langmuir model fits well for Cs+ ion sorption by these adsorbents. The maximum adsorption capacity obtained from Langmuir adsorption isotherm was 0.98 × 10-4 mol/g at 25 °C, and 1.16 × 10-4 mol/g at 50 °C for CS-KT; it was found to be 1.79 × 10-4 mol/g at 25 °C and 2.24 × 10-4 mol/g at 50 °C for CS-KT-M. FT-IR analyses showed that Cs+ sorption occurs by its interaction with CO32-, PO43- and -NH2 groups. The average adsorption energy "E" was calculated as ca.11 kJ/mol from D-R adsorption isotherm. The adsorption kinetics was interpreted well by pseudo-second order model.

Folic acid-modified methotrexate-conjugated gold nanoparticles as nano-sized trojans for drug delivery to folate receptor-positive cancer cells.

Methotrexate (MTX), an analog of folic acid (FA), is a drug widely used in cancer treatment. To prevent its potential toxicity and enhance therapeutic efficacy, targeted drug delivery systems, especially nanotechnology-folate platforms, are a central strategy. Gold nanoparticles (AuNPs) are promising candidates to be used as drug delivery systems because of their small particle sizes and their inertness for the body. In this study, glutathione (GSH)-coated FA-modified spherical AuNPs (5.6 nm) were successfully synthesized, and the anticancer activity of novel MTX-loaded (MTX/Au-GSH-FA) NPs (11 nm) was examined. Dynamic light scattering (DLS) and transmission electron microscopy (TEM) results showed that MTX/AuNPs possess spherical morphology, nanoscaled particle size, narrow size distribution, and good stability. In vitro studies showed that cytotoxicity of MTX/Au-GSH-FA to folate receptor-positive (FR+) human brain (U-87 MG) and cervical (HeLa) cancer cells enhanced significantly (∼3 and ∼10 fold, respectively) compared to free MTX while there was no significant effect in FR-negative human cell lines A549 (lung carcinoma), PC3 (prostate carcinoma), HEK-293 (healthy embryonic kidney). Moreover, the receptor specificity of the conjugate was shown by fluorescent microscopic imaging. In conclusion, these results indicate that the synthesized novel MTX/Au-GSH-FA NP complex seems to be a good candidate for effective and targeted delivery in FR+ cancer therapy.